ist is no longer recommended to
prevent cardiac events, nor is that of calcium channel
blockers, such as diltiazem and verapamil, given their
potential to impair myocardial function in patients with
reduced left ventricular function. Continuation of ACE
inhibitors and angiotensin receptor blockers is based on
individual clinical circumstances.91
Aspirin reduces adverse cardiovascular events among
patients with coronary artery disease and can be
continued during the peri